Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control their sugar levels.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Smart glasses and augmented reality gadgets are considered the next big breakthrough for wearables – and the early iterations of many spectacles are already here. Each has slightly different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback